>>Even the business is 100% failure and all the patents etc. IP worth zero (which is impossible) the stock still worth $2.46 per share now!
I guess you've never invested in a failed biotech before. If things fail, they don't shut-up shop and return the money to shareholders. Instead they spend the remaining cash either on some new project or, more likely, on further attempts to make the old project work.